CCF Funding Part of Important Study and Publication

September 2024, Vol 5, No 3

Nabeel M. Bardeesy, PhD, is a prominent figure in cholangiocarcinoma (CCA) cancer research. He is the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research at Massachusetts General Hospital (MGH), Boston, and associate professor of medicine at Harvard Medical School, Boston.

Dr Bardeesy has contributed significantly to understanding and treating CCA, a rare and aggressive cancer of the bile ducts. He has worked with the Cholangiocarcinoma Foundation (CCF) in multiple capacities, is a CCF Science and Medical Advisory Board emeritus member, and is currently participating in the Cure Cholangiocarcinoma Think Tank (C2T2).

As the leader of the Bardeesy Lab at MGH’s Krantz Family Center for Cancer Research, Dr Bardeesy and his team have published numerous influential studies, including their recent groundbreaking work in the prestigious journal Science titled “Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.” This study highlights the innovative nature of his research and its potential to revolutionize CCA treatment by harnessing tumor immunity. Researching rare cancer and having that work published in Science is a significant achievement for basic scientists because it highlights the groundbreaking nature and high quality of their research and brings critical attention and validation to understudied diseases, potentially accelerating advancements in understanding and treatment.

Dr Bardeesy has become a key advocate for increasing awareness and advancing scientific understanding of this challenging disease through his dedication to CCA research. His efforts inspire the next generation of researchers and drive progress toward more effective treatments for patients with CCA.

Investing in research is vital, and CCF is proud this study was funded partly through C2T2, the CCF Collaboration Award, and the CCF Christopher J. Wilke Memorial and Kathleen and Paul Sidenblad research fellowships. The CCF Research Fellowship Program supports early-career researchers focusing on studies in CCA. Since 2015, the foundation has awarded 60 research fellowships totaling $3.1 million in seed funding to raise awareness about CCA and inspire innovative, high-quality research. Learn more about the fellowship recipients.

The funding CCF donors provide kick-start projects that produce good data and results and attract further investment from bigger funding sources like federal or private foundation grants. This leads to significant discoveries, publications, and collaborative opportunities.

Related Items

The 13th Annual Cholangiocarcinoma Foundation Conference is Approaching!
March 2026, Vol 7, No 1
The Cholangiocarcinoma Foundation (CCF) is thrilled to announce the upcoming 13th Annual Cholangiocarcinoma Foundation Conference, set to take place in Salt Lake City, UT, from May 1-3, 2026, with a virtual option also available.
Cholangiocarcinoma Foundation Announces Upcoming Regional Symposia
December 2025, Vol 6, No 4
The Cholangiocarcinoma Foundation (CCF) is pleased to announce a series of upcoming regional symposia designed to bring together patients, caregivers, clinicians, researchers, and advocates from across the country.
2025 Chicago Cholangiocarcinoma Symposium
September 2025, Vol 6, No 3
The 2025 Chicago Cholangiocarcinoma Symposium, hosted by Dr Anjana Pillai and Dr Andy Liao, will take place on Friday, September 26, from 8:00 am to 4:00 pm, at the Knapp Center for Biomedical Discovery in Chicago, IL.
Shaping the Future of Research: A Recap of the 12th Annual Cholangiocarcinoma Foundation Conference
June 2025, Vol 6, No 2
The Cholangiocarcinoma Foundation 12th Annual Conference marked a milestone in global collaboration. It brought together scientists, academic researchers, advocates, industry partners, patients, and caregivers to identify the top research priorities in cholangiocarcinoma.
Connect Patients With Cholangiocarcinoma to Essential Educational Videos
March 2025, Vol 6, No 1
The Cholangiocarcinoma Foundation is providing a video series for patients and caregivers. Patients can access informational videos through electronic health records.
CCF’s 12th Annual Conference: Driving Research Priorities for Cholangiocarcinoma Breakthroughs
December 2024, Vol 5, No 4
The 12th annual conference, International Consensus on Research Priorities, aims to accelerate breakthroughs in understanding and treating cholangiocarcinoma by identifying top research priorities through collaboration among patients, caregivers, and experts in 10 specialized working groups.
The 11th Annual CCF Conference Is Approaching
March 2024, Vol 5, No 1
The Cholangiocarcinoma Foundation (CCF) will host the 11th Annual CCF Conference in Salt Lake City, Utah, from April 17 to 19. This article summarizes the conference’s itinerary, overarching goals, and participating speakers.
11th Annual CCF Foundation Conference Set for April 2024
December 2023, Vol 4, No 4
The Cholangiocarcinoma Foundation (CCF) is pleased to announce the 11th Annual Cholangiocarcinoma Foundation Conference in Salt Lake City, UT, April 17-19, 2024.
CCF Celebrates Major Milestone in Connecting Patients and Caregivers to Mentorship Program
September 2023, Vol 4, No 3
The Cholangiocarcinoma Foundation (CCF) is celebrating the 1000th mentor–mentee match and 6 years of their mentoring program, CholangioConnect. CCF has developed unique resources to help patients and caregivers navigate their healthcare journeys.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Profession or Role
Primary Specialty or Disease State